Abstract
Continued Validation of the RBD Symptom Severity Scale (RBDSSS) in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium (P6-13.004)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have